Ang-2 levels in patients with severe active ANCA-associated vasculitis and in the same patients after treatment in the RAVE trial.

All values indicate serum Ang-2 in ng/ml; medians and interquartile ranges are shown. *Comparing the difference (screening minus month 6) to the null distribution (Wilcoxon Signed Rank test); P = 0.57 comparing the differences seen in Month 6 Remission and Month 6 Active, P = 0.6 comparing Remission with Active at month 6 (Wilcoxon Rank Sum test).